Two-Week Central Macular Thickness Reduction Rate &gt;37% Predicts the Long-Term Efficacy of Anti-vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion
Frontiers in medicine